109820 — GENEMATRIX Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapFalling Star

Annual balance sheet for GENEMATRIX, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	12,479	4,798	2,135	1,828	2,239
Net Total Accounts Receivable
Net Total Receivables	6,238	13,227	14,264	14,577	15,224
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	21,113	21,280	19,405	19,568	20,201
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6,168	6,325	6,442	6,014	5,668
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	39,532	31,902	31,354	28,458	27,271
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	5,343	5,006	4,519	4,704	4,677
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	7,211	7,717	8,206	9,231	9,800
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	32,321	24,186	23,148	19,227	17,471
Total Liabilities & Shareholders' Equity	39,532	31,902	31,354	28,458	27,271
Total Common Shares Outstanding